ENTRY       D11031                      Drug
NAME        Netarsudil mesylate (USAN);
            Netarsudil mesilate (JAN);
            Rhopressa (TN)
PRODUCT     RHOPRESSA (Alcon Laboratories)
FORMULA     C28H27N3O3. (CH4SO3)2
EXACT_MASS  645.1815
MOL_WEIGHT  645.7436
CLASS       Ophthalmic agent
             DG03201  Intraocular pressure lowering agent
REMARK      ATC code: S01EX05
            Chemical structure group: DG02692
            Product (DG02692): D11031<US>
            Product (mixture): D11558<US>
EFFICACY    Antiglaucoma, Rho-associated kinase inhibitor
  DISEASE   Open-angle glaucoma [DS:H00612]
TARGET      ROCK [HSA:6093 9475] [KO:K04514 K17388]
  PATHWAY   hsa04022(6093+9475)  cGMP-PKG signaling pathway
            hsa04270(6093+9475)  Vascular smooth muscle contraction
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
                S01EX Other antiglaucoma preparations
                 S01EX05 Netarsudil
                  D11031  Netarsudil mesylate (USAN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Ophthalmic Agents
              Intraocular Pressure Lowering Agents
               Netarsudil
                D11031  Netarsudil mesylate (USAN)
            Drug groups [BR:br08330]
             Ophthalmic agent
              DG03201  Intraocular pressure lowering agent
               DG02692  Netarsudil
                D11031  Netarsudil mesylate
            Drug classes [BR:br08332]
             Ophthalmic agent
              DG03201  Intraocular pressure lowering agent
               D11031  Netarsudil mesylate
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Serine/threonine kinases
               AGC group
                ROCK
                 D11031  Netarsudil mesylate (USAN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11031
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11031
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11031
            Drug groups [BR:br08330]
             Ophthalmic agent
              DG03201  Intraocular pressure lowering agent
               DG02692  Netarsudil
DBLINKS     CAS: 1422144-42-0
            PubChem: 350078350
ATOM        44
            1   C8x C    10.2929  -15.4754
            2   N5x N    10.2929  -16.8759
            3   C8x C    11.5533  -17.5762
            4   C8y C    12.7437  -16.8759
            5   C8y C    12.7437  -15.4754
            6   C8x C    11.5533  -14.7752
            7   C8x C    13.9341  -17.5762
            8   C8x C    15.1946  -16.8759
            9   C8y C    15.1946  -15.4754
            10  C8x C    13.9341  -14.7752
            11  N1b N    16.3850  -14.7752
            12  C5a C    17.5754  -15.4754
            13  C1c C    18.7658  -14.7752
            14  C8y C    19.9562  -15.4754
            15  O5a O    17.5754  -16.8759
            16  C1b C    18.7658  -13.3747
            17  N1a N    19.9562  -12.6745
            18  C8x C    19.9562  -16.8759
            19  C8x C    21.1466  -17.5762
            20  C8y C    22.4071  -16.8759
            21  C8x C    22.4071  -15.4754
            22  C8x C    21.1466  -14.7752
            23  C1b C    23.5975  -17.5762
            24  O7a O    24.7879  -16.8759
            25  C7a C    25.9783  -17.5762
            26  C8y C    27.1687  -16.8759
            27  O6a O    25.9783  -18.9766
            28  C8y C    28.4291  -17.5762
            29  C8x C    29.6195  -16.8759
            30  C8y C    29.6195  -15.4754
            31  C8x C    28.4291  -14.7752
            32  C8x C    27.1687  -15.4754
            33  C1a C    28.4291  -18.9766
            34  C1a C    30.8099  -14.7752
            35  S4a S    36.2600  -16.4500
            36  O1d O    34.8600  -16.4500
            37  C1a C    37.6600  -16.4500
            38  O1d O    36.2600  -15.0500
            39  O1d O    36.2600  -17.8500
            40  S4a S    36.2600  -16.4500
            41  O1d O    34.8600  -16.4500
            42  C1a C    37.6600  -16.4500
            43  O1d O    36.2600  -15.0500
            44  O1d O    36.2600  -17.8500
BOND        45
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     4   7 1
            8     7   8 2
            9     8   9 1
            10    9  10 2
            11    5  10 1
            12    9  11 1
            13   11  12 1
            14   12  13 1
            15   13  14 1
            16   12  15 2
            17   13  16 1 #Down
            18   16  17 1
            19   14  18 2
            20   18  19 1
            21   19  20 2
            22   20  21 1
            23   21  22 2
            24   14  22 1
            25   20  23 1
            26   23  24 1
            27   24  25 1
            28   25  26 1
            29   25  27 2
            30   26  28 2
            31   28  29 1
            32   29  30 2
            33   30  31 1
            34   31  32 2
            35   26  32 1
            36   28  33 1
            37   30  34 1
            38   35  36 1
            39   35  37 1
            40   35  38 2
            41   35  39 2
            42   40  41 1
            43   40  42 1
            44   40  43 2
            45   40  44 2
BRACKET     1    33.1100  -18.6900   33.1100  -14.2100
            1    39.4100  -14.2100   39.4100  -18.6900
            1  2
  ORIGINAL  1   35  36  37  38  39
  REPEAT    1   40  41  42  43  44
///
